陽光城(000671.SZ):陽光智博100%換股萬物雲4.8% 撤回H股上市申請文件
陽光城(000671.SZ)發公告指,公司及附屬上海陽光智博生活服務各股東,計劃以持有的陽光智博100%股權,戰略投資萬物雲空間科技服務Pre-IPO融資,換取萬物雲4.8%股份,各股東按照各自持股比例換股。交易完成後,公司將不再直接持有陽光智博股權,並計劃增持萬物雲至5%以上。
監於公司擬開展上述戰略合作,經審慎決策,陽光城決定終止籌劃陽光智博的H股上市,並撤回申請文件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.